In today’s briefing:
- CX Daily: Could Pfizer’s Drug Paxlovid Change China’s Covid Policy?
- Risks to Russian Bonds from Escalating Sanctions
- CX Daily: Oil Prices Surge Amid Russian Assault on Ukraine
CX Daily: Could Pfizer’s Drug Paxlovid Change China’s Covid Policy?
In Depth: Could Pfizer’s drug Paxlovid change China’s Covid policy?
Shackled mother was sold into forced marriages at least three times, probe finds
China loosens new mobile payment rules to put small businesses at ease
Risks to Russian Bonds from Escalating Sanctions
- Following the invasion of Ukraine by Russia, it is only a matter of time before the US and other western allies impose a new set of economic sanctions on Russia
- A directive from the US Treasury this week expanded the restrictions on Russian bonds as it prohibits participating in the secondary market of new bonds, thereby cutting financing for Russia.
- With new sanctions on the way, the risks to Russian bonds have increased. I list the possible risks for holders of Russian bonds under different scenarios.
CX Daily: Oil Prices Surge Amid Russian Assault on Ukraine
Oil prices surge amid Russian assault on Ukraine
China’s annual rural policy road map urges better protection for women and children
Exclusive: China’s banks told to stop taking liberties with ‘agreement deposits’
Before it’s here, it’s on Smartkarma
